Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in lima, peru

Clinical Infectious Diseases

Volumn 48, Issue 10, 2009, Pages 1413-1419

  Palacios, Eda ^a,g   Dallman, Rebecca ^c   Muñoz, Maribel ^a   Hurtado, Rocio ^d   Chalco, Katiuska ^a   Guerra, Dalia ^a   Mestanza, Lorena ^a   Llaro, Karim ^a   Bonilla, Cesar ^b   Drobac, Peter ^e   Bayona, Jaime ^a   Lygizos, Melissa ^f   Anger, Holly ^a   Shin, Sonya ^e  

^a Socios En Salud   (Peru)

^b National Tuberculosis Program   (Peru)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g SOCIOS EN SALUD   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; PROTIONAMIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; RIFABUTIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; DETERIORATION; DRUG TREATMENT FAILURE; FEMALE; FETUS DISTRESS; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; NEWBORN; OUTCOME ASSESSMENT; PERU; PREGNANCY; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; STILLBIRTH; ANIMAL; MIDDLE AGED; PREGNANCY COMPLICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; INFANT, NEWBORN; MIDDLE AGED; PERU; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 65549132367     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598191     Document Type: Article

References (26)

1. Aziz MA, Wright A, Laszlo A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006;368:2142-54.
2. Mukherjee JS, Rich ML, Socci AR, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004;363: 474-81.
3. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 2003. Available at: http://whqlibdoc.who.int/hq/ 2003/wHO-CDS-TB-2003.313-eng.pdf. Accessed 24 July 2008.
4. Margono F, Mroueh J, Garely A, White D, Duerr A, Minkoff HL. Resurgence of active tuberculosis among pregnant women. Obstet Gy- necol 1994;83:911-4.
5. Ormerod P. Tuberculosis in pregnancy and the puerperium. Thorax 2001;56:494-9.
6. Schaefer G, Zervoudakis IA, Fuchs FF, David S. Pregnancy and pulmonary tuberculosis. Obstet Gynecol 1975;46:706-15.
7. Craig GM, Booth H, Story A, et al. The impact of social factors on tuberculosis management. J Adv Nurs 2007;58:418-24.
8. Nitta AT, Milligan D. Management of four pregnant women with multidrug-resistant tuberculosis. Clin Infect Dis 1999;28:1298-304.
9. Starke JR. Tuberculosis: an old disease but a new threat to the mother, fetus, and neonate. Clin Perinatol 1997;24:107-27.
10. Shin S, Guerra D, Rich M, et al. Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases. Clin Infect Dis 2003;36:996-1003.
11. Lessnau KD, Qarah S. Multidrug-resistant tuberculosis in pregnancy: case report and review of the literature. Chest 2003;123:953-6.
12. Drobac PC, del Castillo H, Sweetland A, et al. Treatment ofmultidrug-resistant tuberculosis during pregnancy: long-term follow-up of6 children with intrauterine exposure to second-line agents. Clin Infect Dis 2005;40:1689-92.
13. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003;348:119-28.
14. Partners in Health. Multidrug-resistant tuberculosis curriculum. Available at: http://model.pih.org/mdr-tb-curriculum. Accessed 1 October 2008.
15. Laserson KF, Thorpe LE, Leimane V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005;9:640-5.
16. Mitnick CD, Shin SS, Seung KJ, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008;359:563-74.
17. Ali MM, Cleland J, Shah IH. Trends in reproductive behavior among young single women in Colombia and Peru: 1985-1999. Demography 2003;40:659-73.
18. Alarcon JO, Johnson KM, Courtois B, et al. Determinants and prevalence of HIV infection in pregnant Peruvian women. AIDS 2003;17: 613-8.
19. World Health Organization. Statistical Information System. 2006. Available at: http://www.who.int/whosis/data/Search.jspTindicators = [Indicator].[MBD].Members#. Accessed 1 July 2008.
20. World Health Organization. Neonatal and perinatal mortality: country, regional and global estimates. 2006. Available at: http://www.who.int/ making-pregnancy-safer/publications/neonatal.pdf. Accessed 1 October 2008.
21. Figueroa-Damian R, Arredondo-Garcia JL. Neonatal outcome ofchil- dren born to women with tuberculosis. Arch Med Res 2001; 32:66-9.
22. Figueroa-Damian R, Arredondo-GarciaJL. Pregnancyandtuberculosis: influence of treatment on perinatal outcome. Am J Perinatol 1998;15:303- 6.
23. Jana N, Vasishta K, Jindal SK, Khunnu B, Ghosh K. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet 1994;44:119-24.
24. Adhikari M, Pillay T, Pillay DG. Tuberculosis in the newborn: an emerging disease. Pediatr Infect Dis J 1997;16:1108-12.
25. Hageman JR. Congenital and perinatal tuberculosis: discussion of difficult issues in diagnosis and management. J Perinatol 1998;18:389-94.
26. Marais BJ, Gie RP, Schaaf HS, et al. The clinical epidemiology ofchild- hood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004;8:278-85.